Welcome
Support Centre
30 July 2010 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Metformin in women with cardiac syndrome X: a randomised double blind placebo controlled trial
Source of recordUK Trials
ISRCTNISRCTN28863939
Date ISRCTN assigned31/01/2002
Local reference number(s)PG/99124
Public titleMetformin in women with cardiac syndrome X: a randomised double blind placebo controlled trial
Scientific title
AcronymN/A
Disease/condition/study domainCardiac syndrome X
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaWomen, post menopausal but less than 70 years with Cardiac Syndrome X (definition angina/positive exercise test/normal coronary arteriogram)
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/01/1997
Anticipated end date01/01/2001
Status of trialCompleted
Target number of participantsNot provided at time of registration
Interventions1. Metformin 500 mg twice daily (BD)
2. Matching placebo 1 tab BD

Both treatments will continue for 8 weeks.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
PublicationsResults in: http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16949486
Sources of fundingBritish Heart Foundation (UK)
Sponsor nameBritish Heart Foundation
Sponsor details14 Fitzhardinge Street
London
United Kingdom
W1H 6DH
Sponsor telephone+44 (0)20 7935 0185
Sponsor fax+44 (0)20 7486 5820
Sponsor emailresearch@bhf.org.uk
Contact nameDr N Sattar
Contact detailsUniversity Department of Pathological Biochemistry
Glasgow Royal Infirmary
Glasgow
United Kingdom
G31 2ER
Contact telephone+44 (0)141 211 4312
Contact fax+44 (0)141 553 2558
Contact emailnsattar@clinmed.gla.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN28863939
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central